Cardiac surgery and interventional cardiology are two major segments that make up the cardiovascular disease (CVD) market. Cardiac surgery is focused on cardiovascular procedures involving the repair or replacement of the heart, its valves, bypassing damages or occluded vessels, and other procedures to improve the functions of the cardiovascular system with a wide variety of devices. Interventional cardiology is focused on minimally invasive treatments for structural and functional heart disease using catheter-based approaches. Generally, these procedures include devices such as catheters, guide wires, and stents and so on.
Stents occupy the dominant share among all the devices used in interventional cardiology worldwide. The technological advances in the field of medicine and surgery have led to inventions such as bio-absorbable or biodegradable stents which are currently largely being used in interventional cardiac surgeries, thereby being one of the primary factors driving the global surgical and interventional cardiology devices market.
The global Cardiology Surgical & Interventional Cardiology market was valued at $XXbn in 2015 and is growing at a CAGR of around XX% through 2020.
The US is the largest market for Cardiology Surgical & Interventional Cardiology devices owing to factors such as high healthcare expenditures, patient awareness levels and sophisticated healthcare infrastructure. On the contrary, APAC is expected to show largest growth in the market owing to the presence of high unmet medical needs mainly coming from China and Japan. The increasing prevalence of cardiovascular diseases is the leading factor driving the market. Other factors contributing to the market growth include aging population, sedentary lifestyle and changing dietary habits, innovations in the field cardiology as well as the rise in number of interventional cardiologists, and increasing demand for minimally invasive surgical techniques.
The global cardiology surgical & interventional cardiology devices market is dominated by stents and the global market for the stents used in cardiovascular operations (coronary stents) has a dominant presence in the U.S. owing to the rapidly aging population in North America. It is followed by the European countries and Japan.
Sample Companies Profiled in this Report are:
- C.R. Bard, Inc.
- Cook Medical
- Edwards Lifescience Corp.
- Johnson & Johnson